Jindan Yu
7Patents
1h-index
4Co-inventors
40Inventor score
Filing activity: Jan 18, 2008 → May 2, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7968294B2 | SLIT2 underexpression in metastatic prostate cancer | Chemistry; Metallurgy | 1 | Active |
| US12042543B2 | Substituted 3-amino-5-phenylbenzamide compounds as covalent inhibitors of enhancer zeste homolog 2 (EZH2) and proteolysis-targeting chimeric derivatives thereof (PROTACs) that induce degradation of EZH2 | Human Necessities | 0 | Active |
| US11981678B2 | Substituted [1,2,4]triazolo[4,3-c]pyrimidin-5-amines and proteolysis-targeting chimeric derivatives thereof (PROTACs) that induce degradation of embryonic ectoderm development (EED) protein | Chemistry; Metallurgy | 0 | Active |
| US11919855B2 | Substituted pyrrolidones and piperidones as small molecule inhibitors of EZH2 and EED protein binding | Chemistry; Metallurgy | 0 | Active |
| US8058003B2 | ADRB2 cancer markers | Chemistry; Metallurgy | 0 | Active |
| US8143232B2 | Gene fusion targeted therapy | Chemistry; Metallurgy | 0 | Active |
| US8900819B2 | ADRB2 cancer markers | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.